EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine

Takashi Matono, Shotaro Suzuki, Shuichi Mori, Manabu Ato

The American Journal of Tropical Medicine and Hygiene · 2024

DOI: 10.4269/ajtmh.22-0637 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Takashi Matono und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Aso Iizuka Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Leprosy, Leprosy, Borderline, Skin Diseases, Bacterial, Hypersensitivity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leprosy is a global health issue, causing long-term functional morbidity and stigma. Rapid diagnosis and appropriate treatment are important; however, early diagnosis is often challenging, especially in nonendemic areas. Here, we report a case of borderline lepromatous leprosy accompanied by dapsone-induced (neutropenia, anemia, and methemoglobinemia) and clofazimine-induced (skin discoloration and ichthyosis) side effects and type 1 leprosy reactions during administration of the multidrug therapy. The patient completely recovered without developing any deformities or visual impairment. To ensure early diagnosis and a favorable outcome, clinicians should be aware of the diminished sensation of skin lesions as a key physical finding and manage the drug toxicities and leprosy reactions appropriately in patients on multidrug therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeprosyLeprosy, BorderlineSkin Diseases, BacterialHypersensitivityPeripheral Nervous System DiseasesLeprosy, MultibacillaryLeprosy, LepromatousHumansClofazimineDapsoneDrug Therapy, CombinationLeprostatic Agents

Substanzen

ClofazimineDapsoneLeprostatic Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Aso Iizuka Hospital, Fukuoka, Japan.
  • Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

Zitieren

APA

Matono, T., Suzuki, S., Mori, S., & Ato, M. (2024). Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.22-0637

Vancouver

Matono T, Suzuki S, Mori S, Ato M. Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.22-0637

BibTeX
@article{Matono2024,
  author = {Matono, Takashi and Suzuki, Shotaro and Mori, Shuichi and Ato, Manabu},
  title = {Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2024},
  doi = {10.4269/ajtmh.22-0637}
}
Kostenlos starten →